Connect with us

Cannabis News

Trucking Industry Group Is ‘Deeply Concerned’ About Marijuana Rescheduling’s Potential Impact On Drug Testing For Drivers

Published

8 months ago

on

American truck associations (ATA) say that “very worried” is in drug testing programs.

Sean Duffy Sean Duffy, Dan Horvath, said Dan Horvath. Dan Horvath is capable of achieving the authority and ability to control the transport employees of the marijuana commercial engine (CMV) and security staff “.

Of course, this policy has not yet been prescribed. And while President Donald Trump said he will take a decision about the recently mentioned proposal in the week-Txo protect the reform on the route of the campaign last year – should be seen whether he wants to continue the restoration.

Horvath said that the door “does not have a formal position to legalize or deregulation,” we are very worried about re-programming safety risks, testing the authority and technical requirements for the necessary security staff. “

Concern is a potential guideline for the compulsory federal drug test if they will now be transferred to the Cannabis III Program.

“If so, dot programs to keep programs without cleaning, to maintain marijuana testing authority, and such federal policy changes can be serious consequences for highway safety and national transport network,” letters said. “This risk is not a proven standard, a highly accepted standard before the roadside or before the driver starts working before the vehicle is harder to prevent driving disability.”

“The implications of a gap in the test authority are well documented in the implications of potential security,” Horvath said, pointing to the data The rate of Positive Thc among the driver And research showed the increase in traffic death after state legalization.

“The door has repeatedly transmitted these concerns, and our demand about potential clarity, in the DOT test program, according to the previous administration, both in discussions about formal letters and people”. new According to transport issues.

Horvath also noticed Pete Buttigieg while the Secretary of Transportation has told a conference committee last year Rescheduling would not affect drug testing regulationsAta “never received Answer to our correspondence Explain the basis of this position or explain the details that intend to deal with impacts in the program. “

“The public attention of marijuana policy and marijuana is a federal novelty, we want to effectively coordinate the change in the HHS (Department of Justice) to ensure the authority, tools and technical skills in controlling federal policy.”

Meanwhile, a policy in a couple of companies in the truck industry premiered in April, which sought was approximately 80,000 drivers Positive to marijuana says staff had aggravated Zero-tolerance drug policy below dot.

MARIHUANA Moving III “dot regulations and drug test protocols”, papers, for example, recognizing legal medical use and reducing social stigma, but should not be facilitated.

Dot drug screening program usually uses urinary-based tests, but the report says that Saliva and hair follicle test provides benefits in this standard. It is warned that “there is no extended test today to determine whether a driver is exposed to a drug like THC.”

The Department ended the new test policy in 2023 Allow oral salt drug testing as an alternative to testing based on urine. Late Last last year, critics fell more than half years after the end of the authority, Fixed officials had yet to use the necessary infrastructure to use the new test procedure.

Legislators of Congress Auditions in March The truck industry representatives heard that they called the use of hair follicle tests in the industry. President of the National Transport Safety Commission (NTSB) recommended better education for drivers.

In April, the US Supreme Court A Cannabis company sued for a truck after shooting for a positive THC test He said consuming the CBD product derived from hemp.

Separately, substance abuse and mental health services administration (Samhsa) Official Criticism of a drug testing drug testing “means a drug test” means Canavies use cannabis to do with the nearby impunityA couple of days while avoiding drug test. “

The Transport Industry also recommended the Congress in January If Marijuana is federally restructuring, businesses do not ensure that zero tolerance policies do not need drivers-The key problem of the questionnaire is lacking technology to detect driving handicap.

Report of the 2023 Congress of Congress of Transport, Housing and Urban Development and Related Agencies (Thud), the House Credit Committee “Marijuana impairment measurement measurement is continued to measure the measurement test measurement of sobriety tests to ensure highway security. “

A year earlier in Colorado John Hickenlooper (D) Senin sent the letter to the point Looking for an update in this state of a federal report In the roads that inhibit the development of standardized marijuana deterioration on the roads. The Department Report had to complete Under a large-scale infrastructure bill Then signed by President Joe Biden, but The deadline he reported.

Meanwhile, the National Transport Safety Commission (NTSB) warned Marijuana again program “blind places” to test federally regulated employee tests in security sensitive positions.

On the home committee, then the Dot Secretary mentioned concerns about the door “about the general public” Effects of Highway National System Appeal and Safety Conclusions And his users, “Truck Associations were thrown in a letter to the secretary.

The current federal laws promise to abstain by commercial drivers from cannabis to different types of drug performances, pre-work, random tests.

In June 2022, they found the ATRI survey of the US Licensed Truck Drivers 72.4 percent “release” supports cannabis law and test policies. Another 66.5, 66.5 said Marijuana had to be legalized federally.

Cannabis deforms reforms, while, too The federal civil servant called the “discriminatory” drug test practice around the truck industry.

Fargo Analysis A top well said in 2022 that the main reason for raising costs and staff in the transport sector: marijuana criminalization and As a result, drug testing orders This follows as more states legalize.

Later representative. Earl Blumenoer (or) sent a letter to Motura in 2022, emphasizing that they are policies about the drug testing truck and commercial marijuana useless people cost their work And it helps supply chain problems.

2022 ATRI reports that the impact of cannabis is affected and the impact on motorway security is currently confused, complicating the judgment to correct the problem. A separate 2019 Congress Research Service Report (CRS) It has also been found that evidence of the decline in cannabis is not inclusive.

Read ata’s print Maryhuana rewrite and drug testing followed:

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

(Tagstotranslate) highlighted

Related Topics:
Continue Reading

Cannabis News

Nascent medical cannabis industry aims for growth

Published

8 hours ago

on

April 18, 2026

By











The medicinal cannabis sector is struggling to take root, and another specialist processing plant is set to close. But with current regulations and a new collective industry in mind, New Zealanders are promising to reduce their reliance on imported medicinals.

There was great excitement when medicinal cannabis was legalized and then regulated in 2020, with the hope of growing the domestic sector and serving patients here and abroad. However, since then, several companies have closed their doors, including Greenfern Industries, Cannasouth and, most recently, Helius Therapeutics.

The latter plans to close the East Tāmaki plant, affecting 65 workers. It is one of the few medicinal cannabis factories in the entire nation that has a specialized processing certificate called “Good Manufacturing Practice” (GMP).

Medical Cannabis Council executive director Sally King said that under current rules, most growers did not have such certification, and could only sell raw ingredients, not processed products such as more profitable cannabis capsules.

Read more at the town










Continue Reading

Cannabis News

Medical Marijuana Helps People Stop Using Opioids, Sleeping Aids And Other Prescription Drugs, Study Shows

Published

8 hours ago

on

April 17, 2026

By

Using medical marijuana appears to help reduce the use of other medications, including opioids, sleep aids and antidepressants, according to a new study of more than 3,500 patients. They experience far fewer negative side effects after switching from prescription drugs to cannabis.

The survey results show that across all medication categories, patients were able to reduce their use of other prescription drugs by an average of 84.5 percent after starting to use medical cannabis.

More than half of the patients (58.9 percent) completely stopped using other prescription drugs.

The study, conducted and published by medical cannabis and telehealth company Bloomwell, conducted an online survey of 3,528 patients in Germany last month.

“Through the use of medical cannabis, patients were able to reduce their use of other prescription medications by an average of 84.5% across all categories.”

93.4 percent of patients taking sleeping pills were able to cut their use in half after starting medical marijuana, and 75.5 percent were able to get off the medication completely.

For methylphenidate, an ADHD drug sold under the name Ritalin, 77.3 percent of medical marijuana patients stopped completely.

61 percent of patients who were previously dependent on opioids were able to stop completely with the help of medical marijuana.

Stopping the use of prescription drugs led to a significant reduction in drug-related side effects, with 60.7 percent reporting no longer experiencing them.

“These patient reports demonstrate that in many cases, in addition to the treatment of the actual symptoms, one of the key reasons for an individual therapeutic trial with medical cannabis is the absence or reduction of medication-related side effects,” the study concluded.

“60.7% of patients reported no longer experiencing medication-related side effects from using medical cannabis.”

There were positive side effects, however, with 67.8 percent saying medical cannabis helped them concentrate better, 61.9 percent said it helped them foster more social relationships, and 53.9 percent experienced fewer sick days from work.

“The primary reason for prescribing medicinal cannabis, in addition to treating symptoms, is to reduce or avoid the side effects of other medications,” Julian Wichmann, Bloomwell’s founder and CEO, said in a press release. “For example, anyone who can completely stop opioids using medical cannabis has a good chance of going about their daily lives and working without side effects.”

“So we shouldn’t demand restrictions on access to medical cannabis, but rather make sure doctors are willing to do an individual therapeutic trial with medical cannabis, or at least recommend it and refer patients to their colleagues,” he said. “At the same time, our survey shows that we should finally discuss the great benefits of medical cannabis more openly, instead of only warning about the empirically unproven risks and discrediting the flower.”

This is not the first study to position medical cannabis as a safer alternative to opioids and other prescription drugs.

About One in three Americans who use CBD say they take it as an alternative or supplement to at least one medication—especially painful ones—according to a federally funded study published in February.

Also, a recent federally funded study, published by the American Medical Association (AMA), added further evidence Marijuana can be an effective substitute for opioids in the treatment of chronic pain.

Other studies published by the AMA have found legalizing marijuana for medical or recreational purposes “Significantly associated with reduced opioid use among patients diagnosed with cancer.”

A separate paper published in October also found that Legalizing medical marijuana “is associated with a significant reduction in opioid prescriptions.”

In August, however, Australian researchers published a study that shows this Marijuana can be an effective substitute for opioids in pain management treatment.

Another study published last year in the journal Drug and Alcohol Review found that daily drug users with chronic pain cannabis use was associated with greater likelihood of opioid cessation-Especially among men.

Other studies also found this legalizing medical cannabis appears to have significantly reduced payments to doctors from opioid manufacturers who specialize in pain, the authors found that “this reduction is a consequence of the availability of medical marijuana as a substitute” for prescription analgesics.

Other recent studies also showed a decline in fatal opioid overdoses in jurisdictions where marijuana was legalized for adults. That research found a ‘consistent negative relationship’ between legalization and fatal overdoses, effects more pronounced in states that legalized cannabis earlier in the opioid crisis. The authors estimated that legalizing recreational marijuana “is associated with a decrease of 3.5 deaths per 100,000 people.”

“Our findings suggest that expanding access to recreational marijuana could help combat the opioid epidemic,” the report said. “Prior studies overwhelmingly indicate that marijuana (especially for medical use) can reduce opioid prescriptions, and we see it successfully reducing overdose deaths as well.”

Another recently published report on prescription opioid use in Utah follows the state legalizing medical marijuana found that the availability of legal cannabis reduced opioid use among chronic pain patients and helped reduce prescription drug overdose deaths across the state. Overall, the study’s results indicated that “cannabis plays a significant role in pain management and reducing opioid use,” he said.

President Donald Trump said in December that marijuana can “make people feel a lot better.” and serves as a “substitute for addictive and potentially deadly opioid painkillers.” issued an executive order to federally regulate cannabis and promote access to CBD for therapeutic purposes. He clarified, however, that he personally has no interest in using marijuana himself.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

More employees mobilize with UFCW

Published

1 day ago

on

April 17, 2026

By

United Food and Commercial Workers (UFCW) Local 360 has announced that more cannabis workers in New Jersey are joining its union family. Workers at Hamilton, New Jersey-based cannabis product manufacturer Sun Extractions chose to unionize with Local 360 for the better wages, benefits and benefits that come with a union contract.

Their decision adds to the growing momentum of UFCW Local 360’s Cannabis Workers Rising campaign, which has helped shape statewide labor standards and increase worker, consumer and community safety in New Jersey’s fledgling legal marijuana industry.

“New Jersey’s cannabis industry is stronger today thanks to this vote by Sun Extractions workers,” said Hugh Giordano, UFCW Local 360 Organizing Director. “Sustainable success for companies, workers and communities starts with fair treatment, strong standards and shared commitments. This is how jobs in the cannabis industry become long-term careers, and the future these workers work for.”

“It’s great that this vote is being announced before 4/20,” Giordano added. “4/20 used to be about the plant, but it has become a holiday that celebrates the entire cannabis community and recognizes the workers who grow, cut, pack, package, advise and distribute our cannabis products. Their hard work is why New Jersey’s medical and adult markets are safe and growing, and why sales are on target to exceed $2 billion this year.”

UFCW Local 360 President Sam Ferraino, Jr. emphasized that the Sun Extractions vote is part of a growing push to improve worker protections and benefits in the legal marijuana industry.

“We have more reasons than ever to celebrate 4/20 this year. We welcome the employees of Sun Extractions to the Local 360 family, seeing the hard work of our members move an entire industry forward, and speaking to other states, looking to New Jersey as a model of how to do it,” said Ferraino. “It’s further proof of what we always say: stronger unions mean stronger industries and communities. And that’s worth celebrating.”

For more than a decade, UFCW Local 360 has been at the forefront of efforts to ensure that New Jersey’s cannabis industry offers fair wages, strong job protections and real advancement opportunities. Thousands of cannabis workers, from cultivation to retail, have joined the union since the Cannabis Workers Rising campaign began.

From seed to sale, UFCW is the national leader in organizing workers in the cannabis industry and is the official cannabis union of the AFL-CIO. In the US, UFCW works with workers and business owners to achieve the shared goal of a regulated cannabis industry that provides family-supporting jobs and promotes social equity.

For more information:
UFCW
www.ufcw.org

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media